Metabolism-based targeting of MYC via MPC-SOD2 axis-mediated oxidation promotes cellular differentiation in group 3 medulloblastoma
Abstract Group 3 medulloblastoma (G3 MB) carries the worst prognosis of all MB subgroups. MYC oncoprotein is elevated in G3 MB tumors; however, the mechanisms that support MYC abundance remain unclear. Using metabolic and mechanistic profiling, we pinpoint a role for mitochondrial metabolism in regu...
Main Authors: | Emma Martell, Helgi Kuzmychova, Esha Kaul, Harshal Senthil, Subir Roy Chowdhury, Ludivine Coudière Morrison, Agnes Fresnoza, Jamie Zagozewski, Chitra Venugopal, Chris M. Anderson, Sheila K. Singh, Versha Banerji, Tamra E. Werbowetski-Ogilvie, Tanveer Sharif |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-05-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-023-38049-9 |
Similar Items
-
Cross-species analysis of SHH medulloblastoma models reveals significant inhibitory effects of trametinib on tumor progression
by: Stephanie Borlase, et al.
Published: (2023-09-01) -
Compensatory cross-talk between autophagy and glycolysis regulates senescence and stemness in heterogeneous glioblastoma tumor subpopulations
by: Emma Martell, et al.
Published: (2023-07-01) -
Characterization of a novel OTX2‐driven stem cell program in Group 3 and Group 4 medulloblastoma
by: Margaret Stromecki, et al.
Published: (2018-04-01) -
Deconstruction of Medulloblastoma Cellular Heterogeneity Reveals Differences between the Most Highly Invasive and Self-Renewing Phenotypes
by: Ludivine Coudière Morrison, et al.
Published: (2013-04-01) -
Combined MEK and JAK/STAT3 pathway inhibition effectively decreases SHH medulloblastoma tumor progression
by: Jamie Zagozewski, et al.
Published: (2022-07-01)